Sortina Pharma AB
Sortina Pharma AB
Description
At Sortina, the overall goal is to create life-saving, world-class small molecule therapeutics targeting sortilin. By using the sortilin approach we aim to develop molecules characterized by superior efficacy and safety, providing novel tools for treatment of cancer, neurodegenerative diseases, and beyond.
Sortina Pharma AB
Address
Erik Dahlbergsgatan 11 A, Gothenburg 41130
Gothenburg, Sweden
Gothenburg, Sweden
Contact
contact@sortinapharma.com
Description
At Sortina, the overall goal is to create life-saving, world-class small molecule therapeutics targeting sortilin. By using the sortilin approach we aim to develop molecules characterized by superior efficacy and safety, providing novel tools for treatment of cancer, neurodegenerative diseases, and beyond.
Matchmaking
Connect with Sortina Pharma AB
This entity is yours?
Update informationPosition on the value chain
With the ultimate aim to create a European alliance for bioproduction in Europe, organisations have joined forces with COBIOE. Discover who are our associates.
Bio-resources and biobanking
- Cells, tissues and humanized xeno-organs
- Biosamples
- Viral, phage or bacterial specimen
Identification of biotherapies
- Target identification
- Target validation
- Screening
Drug design
- Drug assessment
- Drug engineering
- In vitro preclinical studies
Clinical validation
- Clinical trials
- In vivo preclinical validation
- Pre-industrial scale production
Production
- Upstream processes
- Downstream processes
- Quality control
Market access
- CE mark / market authorisation
- Payment / Reimbursement
- Care pathways